Güzin Demirağ

575 total citations
29 papers, 441 citations indexed

About

Güzin Demirağ is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Güzin Demirağ has authored 29 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 7 papers in Cancer Research. Recurrent topics in Güzin Demirağ's work include Inflammatory Biomarkers in Disease Prognosis (8 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). Güzin Demirağ is often cited by papers focused on Inflammatory Biomarkers in Disease Prognosis (8 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). Güzin Demirağ collaborates with scholars based in Türkiye, United States and United Kingdom. Güzin Demirağ's co-authors include İdris Yücel, Yasemi̇n Kemal, Yurdanur Süllü, Fatih Teker, İstemi Yücel, Meltem Özdemir, Arzu Altunçekiç Yıldırım, Bedrı Kandemır, Filiz Karagöz and Ali Yılmaz and has published in prestigious journals such as Journal of Clinical Oncology, BMC Cancer and Clinical Chemistry and Laboratory Medicine (CCLM).

In The Last Decade

Güzin Demirağ

26 papers receiving 434 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Güzin Demirağ Türkiye 10 295 124 108 95 56 29 441
Emi Noguchi Japan 12 352 1.2× 120 1.0× 115 1.1× 208 2.2× 51 0.9× 63 608
Rouzan G. Karabakhtsian United States 13 180 0.6× 181 1.5× 139 1.3× 117 1.2× 115 2.1× 34 599
Öznur Bal Türkiye 12 175 0.6× 108 0.9× 78 0.7× 142 1.5× 60 1.1× 49 380
Seog-Yun Park South Korea 10 170 0.6× 75 0.6× 138 1.3× 172 1.8× 72 1.3× 22 433
Ji Zhou China 16 292 1.0× 91 0.7× 129 1.2× 174 1.8× 43 0.8× 39 621
Barbara Gazić Slovenia 13 140 0.5× 114 0.9× 85 0.8× 80 0.8× 130 2.3× 45 506
Jiaolin Zhou China 13 265 0.9× 122 1.0× 59 0.5× 144 1.5× 195 3.5× 57 528
Kuniko Sunami Japan 16 320 1.1× 196 1.6× 150 1.4× 297 3.1× 47 0.8× 47 638
Xiuxin Han China 16 211 0.7× 123 1.0× 169 1.6× 207 2.2× 138 2.5× 28 517

Countries citing papers authored by Güzin Demirağ

Since Specialization
Citations

This map shows the geographic impact of Güzin Demirağ's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Güzin Demirağ with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Güzin Demirağ more than expected).

Fields of papers citing papers by Güzin Demirağ

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Güzin Demirağ. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Güzin Demirağ. The network helps show where Güzin Demirağ may publish in the future.

Co-authorship network of co-authors of Güzin Demirağ

This figure shows the co-authorship network connecting the top 25 collaborators of Güzin Demirağ. A scholar is included among the top collaborators of Güzin Demirağ based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Güzin Demirağ. Güzin Demirağ is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Demirağ, Güzin, et al.. (2024). Hemoglobin, albumin, lymphocytes and platelets (HALP) score as a predictor of survival in patients with glioblastoma (GBM). BMC Neurology. 24(1). 260–260. 1 indexed citations
3.
Demirağ, Güzin, et al.. (2022). Prospective evaluation of hematological parameters in preoperative renal cell cancer patients. BMC Urology. 22(1). 201–201. 6 indexed citations
4.
Demirağ, Güzin, et al.. (2022). A case of castration-resistant metastatic prostate cancer who continued treatment with enzalutamide after epileptic seizure. Journal of Oncology Pharmacy Practice. 29(2). 498–501.
5.
Demirağ, Güzin, et al.. (2021). Predictive Significance of Ki-67 and Platelet Lymphocyte Ratio in Patients with Gastric Cancer Receiving Neoadjuvant FLOT Chemotherapy. Journal of College of Physicians And Surgeons Pakistan. 31(5). 546–552. 5 indexed citations
6.
Yılmaz, Ali, et al.. (2021). Prognostic Significance of Hemoglobin-To-Red Cell Distribution Width Ratio in Patients with Metastatic Renal Cancer. Future Oncology. 17(29). 3853–3864. 28 indexed citations
7.
Demirağ, Güzin, et al.. (2021). Sigmoid Sinus Thrombosis Followed by Splenic Infarction Due to Imatinib Therapy in a Patient with Gastrointestinal Stromal Tumor; Hematological Side Effects of Imatinib. Journal of Pharmacy & Pharmaceutical Sciences. 24. 148–152. 1 indexed citations
9.
Yücel, İdris, et al.. (2018). Systemic immune-inflammation index and neutrophil to lymphocyte ratio for predicting tumor grade in neuroendocrine tumors.. Journal of Clinical Oncology. 36(15_suppl). e16179–e16179. 1 indexed citations
10.
Kemal, Yasemi̇n, et al.. (2016). Virchow's node metastasis: an unusual presentation of ovarian cancer.. PubMed. 37(3). 398–400. 3 indexed citations
11.
Özkan, Elgin, et al.. (2016). Early Response to Everolimus Therapy Detected on 68Ga-DOTATATE PET/CT in a Patient With Pancreatic Neuroendocrine Tumor. Clinical Nuclear Medicine. 41(7). 561–563. 1 indexed citations
12.
Kemal, Yasemi̇n, et al.. (2015). Antithyroid peroxidase antibody positivity is associated with lower incidence of metastasis in breast cancer. Molecular and Clinical Oncology. 3(3). 629–632. 8 indexed citations
13.
Teker, Fatih, et al.. (2015). PRIMARY TESTICULAR LYMPHOMA: A SINGLE CENTRE EXPERIENCE. Experimental Oncology. 37(3). 223–226. 3 indexed citations
14.
Kemal, Yasemi̇n, et al.. (2014). Mean platelet volume could be a useful biomarker for monitoring epithelial ovarian cancer. Journal of Obstetrics and Gynaecology. 34(6). 515–518. 59 indexed citations
15.
Kemal, Yasemi̇n, et al.. (2014). Elevated Serum Neutrophil to Lymphocyte and Platelet to Lymphocyte Ratios Could be Useful in Lung Cancer Diagnosis. Asian Pacific Journal of Cancer Prevention. 15(6). 2651–2654. 100 indexed citations
16.
Erdem, Di̇lek, et al.. (2012). Baseline lymphopenia as a prognostic marker for colorectal carcinoma.. Journal of Clinical Oncology. 30(15_suppl). e14107–e14107. 1 indexed citations
17.
Süllü, Yurdanur, Güzin Demirağ, Arzu Altunçekiç Yıldırım, Filiz Karagöz, & Bedrı Kandemır. (2011). Matrix metalloproteinase-2 (MMP-2) and MMP-9 expression in invasive ductal carcinoma of the breast. Pathology - Research and Practice. 207(12). 747–753. 58 indexed citations
18.
Saip, Pınar, Serkan Keskın, Güzin Demirağ, et al.. (2011). TÜRKİYE’xxDE MEME KANSERLİ HASTALARIN TANI VE TEDAVİ YÖNTEMLERİNE ULAŞIM HIZI ÇOK MERKEZLİ GÖZLEMSEL ÇALIŞMA.. 7(2). 109–117. 2 indexed citations
19.
Demirağ, Güzin, et al.. (2011). Expression of Plakophilins (PKP1, PKP2, and PKP3) in Gastric Cancers. Diagnostic Pathology. 6(1). 1–1. 44 indexed citations
20.
Demirağ, Güzin, Yurdanur Süllü, & İdris Yücel. (2011). Expression of Plakophilins (PKP1, PKP2, and PKP3) in breast cancers. Medical Oncology. 29(3). 1518–1522. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026